IsoPlexis Corp
NASDAQ:ISO
IsoPlexis Corp
Total Liabilities & Equity
IsoPlexis Corp
Total Liabilities & Equity Peer Comparison
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IsoPlexis Corp
NASDAQ:ISO
|
Total Liabilities & Equity
$109.1m
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Total Liabilities & Equity
$97.1B
|
CAGR 3-Years
14%
|
CAGR 5-Years
12%
|
CAGR 10-Years
8%
|
|
Danaher Corp
NYSE:DHR
|
Total Liabilities & Equity
$83.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Total Liabilities & Equity
$3.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
|
Agilent Technologies Inc
NYSE:A
|
Total Liabilities & Equity
$10.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
0%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Total Liabilities & Equity
$26.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
24%
|
See Also
What is IsoPlexis Corp's Total Liabilities & Equity?
Total Liabilities & Equity
109.1m
USD
Based on the financial report for Dec 31, 2022, IsoPlexis Corp's Total Liabilities & Equity amounts to 109.1m USD.
What is IsoPlexis Corp's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 3Y
42%
Over the last year, the Total Liabilities & Equity growth was -42%. The average annual Total Liabilities & Equity growth rates for IsoPlexis Corp have been 42% over the past three years .